RegeneRx

RegeneRx Eyes Pipeline Shuffle in Light of Development Delays
BioSpace
Mon, 08/22/22 - 08:27 pm
RegeneRx
R&D
neurotrophic keratitis
U.S. Patent Office Significantly Extends the Term of Three RegeneRx Patents
Yahoo
Mon, 11/3/14 - 09:52 am
patents
RegeneRx
RegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials in Asia with RGN-259
Yahoo
Mon, 07/7/14 - 10:55 am
RegeneRx
G-treeBNT
dry eye disease
RGN-259
Asia
RegeneRx says Phase 2 trial met primary outcome measure
Yahoo/Fly on the Wall
Mon, 06/24/13 - 10:42 am
RegeneRx
RGN-137
epidermolysis bullosa
China Biotech In Review: GE Seeks To Increase China Revenues By Expanding Beyond Top Tier Markets
Seeking Alpha
Sun, 04/1/12 - 11:46 am
Chongqing Huapont Pharma
RegeneRx
GSK
Hanmi Pharma
Hubei Minkang Pharma
Bayer
GE Healthcare
Roche
RegeneRx Biopharmaceuticals Announces Proposed Public Offering
MarketWatch
Sat, 04/17/10 - 12:50 pm
RegeneRx
IPOs
RegeneRx Reports Phase II Venous Stasis Trial Results
Yahoo
Fri, 03/27/09 - 06:58 am
RegeneRx
venous stasis
RGN-137
RegeneRx Updates on Phase II Venous Stasis Trial
Yahoo
Thu, 02/26/09 - 12:53 pm
RegeneRx
RGN-137
RegeneRx to Shift Ophthalmic Clinical Development Strategy
Yahoo
Wed, 01/21/09 - 10:43 am
RegeneRx
RGN-259
RegeneRx Reports Phase II Pressure Ulcer Trial Results
Yahoo
Fri, 01/9/09 - 10:10 am
RegeneRx
RGN-137